Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Influence of Donor's Age on Immunomodulatory Properties of Canine Adipose Tissue-Derived Mesenchymal Stem Cells.

Taguchi T, Borjesson DL, Osmond C, Griffon DJ.

Stem Cells Dev. 2019 Oct 5. doi: 10.1089/scd.2019.0118. [Epub ahead of print]

PMID:
31588862
2.

Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.

Saldinger LK, Nelson SG, Bellone RR, Lassaline M, Mack M, Walker NJ, Borjesson DL.

Vet Ophthalmol. 2019 Aug 22. doi: 10.1111/vop.12704. [Epub ahead of print]

PMID:
31441218
3.

Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation.

Taechangam N, Iyer SS, Walker NJ, Arzi B, Borjesson DL.

Stem Cell Res Ther. 2019 Jun 25;10(1):188. doi: 10.1186/s13287-019-1300-3.

4.

Ultrasound-guided injection of the cranial tibial artery for stem cell administration in horses.

Torrent A, Spriet M, Espinosa-Mur P, Clark KC, Whitcomb MB, Borjesson DL, Galuppo LD.

Equine Vet J. 2019 Sep;51(5):681-687. doi: 10.1111/evj.13065. Epub 2019 Jan 28.

PMID:
30623489
5.

ESTABLISHING HEMATOLOGY AND SERUM CHEMISTRY REFERENCE INTERVALS FOR WILD HAWAIIAN MONK SEALS ( NEOMONACHUS SCHAUINSLANDI).

Kaufman AC, Robinson SJ, Borjesson DL, Barbieri M, Littnan CL.

J Zoo Wildl Med. 2018 Dec 13;49(4):1036-1040. doi: 10.1638/2017-0039.1.

PMID:
30592935
6.

Hounsfield units are a useful predictor of pleural effusion cytological type in dogs but not in cats.

Woods SJ, Spriet M, Safra N, Cissell DD, Borjesson DL.

Vet Radiol Ultrasound. 2018 Jul;59(4):405-411. doi: 10.1111/vru.12618. Epub 2018 Apr 23.

PMID:
29687517
7.

Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses.

Barberini DJ, Aleman M, Aristizabal F, Spriet M, Clark KC, Walker NJ, Galuppo LD, Amorim RM, Woolard KD, Borjesson DL.

Stem Cell Res Ther. 2018 Apr 10;9(1):96. doi: 10.1186/s13287-018-0849-6.

8.

Mesenchymal stem cell therapy in cats: Current knowledge and future potential.

Quimby JM, Borjesson DL.

J Feline Med Surg. 2018 Mar;20(3):208-216. doi: 10.1177/1098612X18758590. Review.

PMID:
29478398
9.

A Comparison of Bone Marrow and Cord Blood Mesenchymal Stem Cells for Cartilage Self-Assembly.

White JL, Walker NJ, Hu JC, Borjesson DL, Athanasiou KA.

Tissue Eng Part A. 2018 Aug;24(15-16):1262-1272. doi: 10.1089/ten.TEA.2017.0424. Epub 2018 Apr 2.

10.

Allogeneic Stem Cells Alter Gene Expression and Improve Healing of Distal Limb Wounds in Horses.

Textor JA, Clark KC, Walker NJ, Aristizobal FA, Kol A, LeJeune SS, Bledsoe A, Davidyan A, Gray SN, Bohannon-Worsley LK, Woolard KD, Borjesson DL.

Stem Cells Transl Med. 2018 Jan;7(1):98-108. doi: 10.1002/sctm.17-0071. Epub 2017 Oct 24.

11.

Isolation and characterization of canine placenta-derived mesenchymal stromal cells for the treatment of neurological disorders in dogs.

Long C, Lankford L, Kumar P, Grahn R, Borjesson DL, Farmer D, Wang A.

Cytometry A. 2018 Jan;93(1):82-92. doi: 10.1002/cyto.a.23171. Epub 2017 Jul 17.

12.

Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis.

Arzi B, Clark KC, Sundaram A, Spriet M, Verstraete FJM, Walker NJ, Loscar MR, Fazel N, Murphy WJ, Vapniarsky N, Borjesson DL.

Stem Cells Transl Med. 2017 Aug;6(8):1710-1722. doi: 10.1002/sctm.17-0035. Epub 2017 Jun 15.

13.

Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome.

Clark KC, Fierro FA, Ko EM, Walker NJ, Arzi B, Tepper CG, Dahlenburg H, Cicchetto A, Kol A, Marsh L, Murphy WJ, Fazel N, Borjesson DL.

Stem Cell Res Ther. 2017 Mar 20;8(1):69. doi: 10.1186/s13287-017-0528-z.

14.

Anaplasma phagocytophilum APH0032 Is Exposed on the Cytosolic Face of the Pathogen-Occupied Vacuole and Co-opts Host Cell SUMOylation.

Oki AT, Huang B, Beyer AR, May LJ, Truchan HK, Walker NJ, Galloway NL, Borjesson DL, Carlyon JA.

Front Cell Infect Microbiol. 2016 Sep 22;6:108. eCollection 2016.

15.

Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses.

Owens SD, Kol A, Walker NJ, Borjesson DL.

Stem Cells Int. 2016;2016:5830103. doi: 10.1155/2016/5830103. Epub 2016 Aug 28.

16.

Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.

Kol A, Walker NJ, Nordstrom M, Borjesson DL.

PLoS One. 2016 Feb 12;11(2):e0148568. doi: 10.1371/journal.pone.0148568. eCollection 2016.

17.

Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype.

Clark KC, Kol A, Shahbenderian S, Granick JL, Walker NJ, Borjesson DL.

Stem Cell Rev Rep. 2016 Apr;12(2):245-56. doi: 10.1007/s12015-015-9638-0.

18.

Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats.

Arzi B, Mills-Ko E, Verstraete FJ, Kol A, Walker NJ, Badgley MR, Fazel N, Murphy WJ, Vapniarsky N, Borjesson DL.

Stem Cells Transl Med. 2016 Jan;5(1):75-86. doi: 10.5966/sctm.2015-0127. Epub 2015 Nov 18.

19.

Companion animals: Translational scientist's new best friends.

Kol A, Arzi B, Athanasiou KA, Farmer DL, Nolta JA, Rebhun RB, Chen X, Griffiths LG, Verstraete FJ, Murphy CJ, Borjesson DL.

Sci Transl Med. 2015 Oct 7;7(308):308ps21. doi: 10.1126/scitranslmed.aaa9116. Review.

20.

Feasibility Study of Canine Epidermal Neural Crest Stem Cell Transplantation in the Spinal Cords of Dogs.

McMahill BG, Spriet M, Sisó S, Manzer MD, Mitchell G, McGee J, Garcia TC, Borjesson DL, Sieber-Blum M, Nolta JA, Sturges BK.

Stem Cells Transl Med. 2015 Oct;4(10):1173-86. doi: 10.5966/sctm.2015-0018. Epub 2015 Aug 13.

21.

Cartilage immunoprivilege depends on donor source and lesion location.

Arzi B, DuRaine GD, Lee CA, Huey DJ, Borjesson DL, Murphy BG, Hu JCY, Baumgarth N, Athanasiou KA.

Acta Biomater. 2015 Sep;23:72-81. doi: 10.1016/j.actbio.2015.05.025. Epub 2015 May 28.

22.

Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.

Kol A, Wood JA, Carrade Holt DD, Gillette JA, Bohannon-Worsley LK, Puchalski SM, Walker NJ, Clark KC, Watson JL, Borjesson DL.

Stem Cell Res Ther. 2015 Apr 15;6:73. doi: 10.1186/s13287-015-0050-0.

23.

Thermally labile components of aqueous humor potently induce osteogenic potential in adipose-derived mesenchymal stem cells.

Morgan JT, Kwon HS, Wood JA, Borjesson DL, Tomarev SI, Murphy CJ, Russell P.

Exp Eye Res. 2015 Jun;135:127-33. doi: 10.1016/j.exer.2015.02.018. Epub 2015 Feb 24.

24.

What is your diagnosis? Cerebrospinal fluid from a horse.

Adedeji AO, Borjesson DL, Kozikowski-Nicholas TA, Cartoceti AN, Prutton J, Aleman M.

Vet Clin Pathol. 2015 Mar;44(1):171-2. doi: 10.1111/vcp.12223. Epub 2015 Jan 29. No abstract available.

PMID:
25639591
25.

Equine bone marrow volume reduction, red blood cell depletion, and mononuclear cell recovery using the PrepaCyte-CB processing system.

Burton AG, Clark KC, Borjesson DL, Carrade DD, Burges J, Owens SD.

Vet Clin Pathol. 2015 Jun;44(2):188-93. doi: 10.1111/vcp.12236. Epub 2015 Jan 27.

PMID:
25627833
26.

Scintigraphic tracking of mesenchymal stem cells after portal, systemic intravenous and splenic administration in healthy beagle dogs.

Spriet M, Hunt GB, Walker NJ, Borjesson DL.

Vet Radiol Ultrasound. 2015 May-Jun;56(3):327-34. doi: 10.1111/vru.12243. Epub 2015 Jan 12.

PMID:
25582730
27.

Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development.

Arzi B, Kol A, Murphy B, Walker NJ, Wood JA, Clark K, Verstraete FJ, Borjesson DL.

Stem Cells Dev. 2015 Apr 1;24(7):814-23. doi: 10.1089/scd.2014.0317. Epub 2014 Dec 31.

28.

The Anaplasma phagocytophilum effector AmpA hijacks host cell SUMOylation.

Beyer AR, Truchan HK, May LJ, Walker NJ, Borjesson DL, Carlyon JA.

Cell Microbiol. 2015 Apr;17(4):504-19. doi: 10.1111/cmi.12380. Epub 2014 Nov 22.

29.

Thymoma-associated lymphocytosis in a dog.

Burton AG, Borjesson DL, Vernau W.

Vet Clin Pathol. 2014 Dec;43(4):584-8. doi: 10.1111/vcp.12196. Epub 2014 Oct 8.

PMID:
25295998
30.

Stem cells in canine spinal cord injury--promise for regenerative therapy in a large animal model of human disease.

McMahill BG, Borjesson DL, Sieber-Blum M, Nolta JA, Sturges BK.

Stem Cell Rev Rep. 2015 Feb;11(1):180-93. doi: 10.1007/s12015-014-9553-9. Review.

PMID:
25173879
31.

Immunophenotype and gene expression profile of mesenchymal stem cells derived from canine adipose tissue and bone marrow.

Screven R, Kenyon E, Myers MJ, Yancy HF, Skasko M, Boxer L, Bigley EC 3rd, Borjesson DL, Zhu M.

Vet Immunol Immunopathol. 2014 Sep 15;161(1-2):21-31. doi: 10.1016/j.vetimm.2014.06.002. Epub 2014 Jul 1.

PMID:
25026887
32.

Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions.

Kol A, Foutouhi S, Walker NJ, Kong NT, Weimer BC, Borjesson DL.

Stem Cells Dev. 2014 Aug 15;23(16):1831-43. doi: 10.1089/scd.2014.0128. Epub 2014 Jun 26.

33.

Anaplasma phagocytophilum surface protein AipA mediates invasion of mammalian host cells.

Seidman D, Ojogun N, Walker NJ, Mastronunzio J, Kahlon A, Hebert KS, Karandashova S, Miller DP, Tegels BK, Marconi RT, Fikrig E, Borjesson DL, Carlyon JA.

Cell Microbiol. 2014 Aug;16(8):1133-45. doi: 10.1111/cmi.12286. Epub 2014 Apr 3.

34.

Human trabecular meshwork cells exhibit several characteristics of, but are distinct from, adipose-derived mesenchymal stem cells.

Morgan JT, Wood JA, Walker NJ, Raghunathan VK, Borjesson DL, Murphy CJ, Russell P.

J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):254-66. doi: 10.1089/jop.2013.0175. Epub 2014 Jan 23.

35.

Canine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury.

Gericota B, Anderson JS, Mitchell G, Borjesson DL, Sturges BK, Nolta JA, Sieber-Blum M.

Stem Cells Transl Med. 2014 Mar;3(3):334-45. doi: 10.5966/sctm.2013-0129. Epub 2014 Jan 17.

36.

Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source.

Carrade Holt DD, Wood JA, Granick JL, Walker NJ, Clark KC, Borjesson DL.

Stem Cells Dev. 2014 Jun 1;23(11):1258-65. doi: 10.1089/scd.2013.0537. Epub 2014 Mar 4.

PMID:
24438346
37.

Safety and immunomodulatory effects of allogeneic canine adipose-derived mesenchymal stromal cells transplanted into the region of the lacrimal gland, the gland of the third eyelid and the knee joint.

Park SA, Reilly CM, Wood JA, Chung DJ, Carrade DD, Deremer SL, Seraphin RL, Clark KC, Zwingenberger AL, Borjesson DL, Hayashi K, Russell P, Murphy CJ.

Cytotherapy. 2013 Dec;15(12):1498-510. doi: 10.1016/j.jcyt.2013.06.009. Epub 2013 Aug 29.

PMID:
23992828
38.

Staphylococcus aureus recognition by hematopoietic stem and progenitor cells via TLR2/MyD88/PGE2 stimulates granulopoiesis in wounds.

Granick JL, Falahee PC, Dahmubed D, Borjesson DL, Miller LS, Simon SI.

Blood. 2013 Sep 5;122(10):1770-8. doi: 10.1182/blood-2012-11-466268. Epub 2013 Jul 18.

39.

Characterization of thrombelastography over time in dogs with hyperadrenocorticism.

Kol A, Nelson RW, Gosselin RC, Borjesson DL.

Vet J. 2013 Sep;197(3):675-81. doi: 10.1016/j.tvjl.2013.05.047. Epub 2013 Jul 6.

PMID:
23838206
40.

Mobilization of endogenous stem cell populations enhances fracture healing in a murine femoral fracture model.

Toupadakis CA, Granick JL, Sagy M, Wong A, Ghassemi E, Chung DJ, Borjesson DL, Yellowley CE.

Cytotherapy. 2013 Sep;15(9):1136-47. doi: 10.1016/j.jcyt.2013.05.004. Epub 2013 Jul 3.

41.

Immunomodulation by mesenchymal stem cells in veterinary species.

Carrade DD, Borjesson DL.

Comp Med. 2013 Jun;63(3):207-17. Review.

42.

Serial haemostatic monitoring of dogs with multicentric lymphoma.

Kol A, Marks SL, Skorupski KA, Kass PH, Guerrero T, Gosselin RC, Borjesson DL.

Vet Comp Oncol. 2015 Sep;13(3):255-66. doi: 10.1111/vco.12041. Epub 2013 May 25.

PMID:
23710569
43.

Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.

Sole A, Spriet M, Padgett KA, Vaughan B, Galuppo LD, Borjesson DL, Wisner ER, Vidal MA.

Equine Vet J. 2013 Nov;45(6):726-31. doi: 10.1111/evj.12063. Epub 2013 Apr 9.

PMID:
23574488
44.

The effects of therapeutic concentrations of gentamicin, amikacin and hyaluronic acid on cultured bone marrow-derived equine mesenchymal stem cells.

Bohannon LK, Owens SD, Walker NJ, Carrade DD, Galuppo LD, Borjesson DL.

Equine Vet J. 2013 Nov;45(6):732-6. doi: 10.1111/evj.12045. Epub 2013 Feb 28.

PMID:
23448189
45.

Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells().

Carrade DD, Lame MW, Kent MS, Clark KC, Walker NJ, Borjesson DL.

Cell Med. 2012;4(1):1-11. Epub 2012 Jan 1.

46.

Anaplasma phagocytophilum Asp14 is an invasin that interacts with mammalian host cells via its C terminus to facilitate infection.

Kahlon A, Ojogun N, Ragland SA, Seidman D, Troese MJ, Ottens AK, Mastronunzio JE, Truchan HK, Walker NJ, Borjesson DL, Fikrig E, Carlyon JA.

Infect Immun. 2013 Jan;81(1):65-79. doi: 10.1128/IAI.00932-12. Epub 2012 Oct 15.

47.

Anaplasma phagocytophilum outer membrane protein A interacts with sialylated glycoproteins to promote infection of mammalian host cells.

Ojogun N, Kahlon A, Ragland SA, Troese MJ, Mastronunzio JE, Walker NJ, Viebrock L, Thomas RJ, Borjesson DL, Fikrig E, Carlyon JA.

Infect Immun. 2012 Nov;80(11):3748-60. doi: 10.1128/IAI.00654-12. Epub 2012 Aug 20.

48.

Autologous point-of-care cellular therapies variably induce equine mesenchymal stem cell migration, proliferation and cytokine expression.

Kol A, Walker NJ, Galuppo LD, Clark KC, Buerchler S, Bernanke A, Borjesson DL.

Equine Vet J. 2013 Mar;45(2):193-8. doi: 10.1111/j.2042-3306.2012.00600.x. Epub 2012 Jul 11.

PMID:
22780195
49.

The modulation of canine mesenchymal stem cells by nano-topographic cues.

Wood JA, Ly I, Borjesson DL, Nealey PF, Russell P, Murphy CJ.

Exp Cell Res. 2012 Nov 15;318(19):2438-45. doi: 10.1016/j.yexcr.2012.06.022. Epub 2012 Jul 4.

50.

Hematopoietic stem and progenitor cells as effectors in innate immunity.

Granick JL, Simon SI, Borjesson DL.

Bone Marrow Res. 2012;2012:165107. doi: 10.1155/2012/165107. Epub 2012 Jun 19.

Supplemental Content

Loading ...
Support Center